MIZUHO MEDY CO.,LTD. (4595.T) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	10.8B	11.3B	11.4B	11.0B	17.6B
Cost of Revenue	698.0M	—	—	—	—
Gross Profit	1.5B	7.8B	8.1B	8.1B	14.1B
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	750.0M	3.2B	3.2B	2.9B	3.0B
General & Admin Expense	—	—	—	—	—
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	—	—	—	—	—
Total Operating Expenses	750.0M	3.2B	3.2B	2.9B	3.0B
Cost and Expenses	6.5B	6.6B	6.5B	5.8B	6.5B
Operating Income (EBIT)	4.3B	4.6B	4.9B	5.2B	11.1B
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	—	—	—	—	—
Net Interest Income	—	—	—	—	—
Other Non-Op Income/Expense	—	90.0M	—	—	(33.3M)
Non-Operating Income (excl Interest)	1.0M	2.0M	2.0M	735.0K	572.0K
EBT (Pre-Tax Income)	823.0M	4.7B	5.2B	5.3B	11.1B
Income Tax Expense	222.0M	1.3B	1.4B	1.5B	3.2B
Bottom Line
Net Income	3.2B	3.4B	3.8B	3.8B	7.8B
Earnings from Cont. Ops	—	—	—	—	—
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	3.2B	3.4B	3.8B	3.8B	7.8B
Per Share
Basic EPS	¥171	¥180	¥198	¥396	¥823
Diluted EPS	¥171	—	—	—	—
Revenue Per Share	¥568	¥591	¥600	¥1,154	¥1,846
Shares
Basic Shares Outstanding	19.0M	19.0M	19.0M	9.5M	9.5M
Diluted Shares Outstanding	—	—	—	—	—
Profitability Metrics
EBITDA	—	4.9B	5.1B	5.3B	11.3B
D&A	—	266.0M	228.0M	195.5M	186.6M
EBIT	4.3B	4.6B	4.9B	5.2B	11.1B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026